Pulse Biosciences Inc Current ratio
Quel est le Current ratio de Pulse Biosciences Inc?
Le Current ratio de Pulse Biosciences Inc est 4.57
Quelle est la définition de Current ratio?
Le ratio actuel est un ratio de liquidité qui mesure si une entreprise dispose ou non de ressources suffisantes pour faire face à ses obligations à court terme.
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio des entreprises dans Health Care secteur sur NASDAQ par rapport à Pulse Biosciences Inc
Que fait Pulse Biosciences Inc?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Entreprises avec current ratio similaire à Pulse Biosciences Inc
- Aldeyra Therapeutics Inc a Current ratio de 4.55
- Zoom Video Communications Inc a Current ratio de 4.56
- Douyu International Ltd a Current ratio de 4.56
- BIT Mining Ltd a Current ratio de 4.56
- Achieve Life Sciences a Current ratio de 4.56
- Midwich Plc a Current ratio de 4.57
- Pulse Biosciences Inc a Current ratio de 4.57
- CIM Commercial Trust a Current ratio de 4.58
- Hongkong Chinese a Current ratio de 4.58
- Nuveen California Municipal Value Fund a Current ratio de 4.58
- Talga Resources a Current ratio de 4.58
- Inke a Current ratio de 4.58
- Mayur Uniquoters a Current ratio de 4.58